In honor of Asthma Awareness Month, Pulmonology Advisor interviewed David A. Hill, MD, of the American Lung Association, to highlight the advances in care as well as gaps in knowledge and treatment.
Performing therapeutic bronchoscopy at the time of intensive care unit admission may decrease ventilator-associated pneumonia incidence in patients with level I trauma.
Compared with standard of care tests and most clinical signs, the molecular bacterial load assay demonstrated higher sensitivity and more rapid turnaround times for monitoring tuberculosis treatment.
Patients with pulmonary arterial hypertension experienced a significant improvement in World Health Organization Functional Class when transitioned from a phosphodiesterase type 5 inhibitor to riociguat.
The Xvivo Perfusion System can temporarily ventilate, oxygenate, and pump preservation solution through lungs previously deemed unacceptable for transplant.
An estimated 4 million new pediatric asthma cases per year, or 13% of global incidence, may be attributable to ambient nitrogen dioxide exposure.
Suppressor of tumorigenicity 2 may function as a biomarker to identify patients with pulmonary arterial hypertension with higher REVEAL risk scores.
Sleep apnea severity was associated with elevated pulmonary capillary wedge pressure in adults.
The risk for sudden unexpected infant death increased with any maternal smoking during pregnancy.
Balloon pulmonary angioplasty was considered safe and effective even in patients considered “oldest-old” with chronic thromboembolic pulmonary hypertension.
